| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |